Nicotinamide mononucleotide + huc-mscs

1 paper3 findings

1 lab in 1 country

Funder: National Natural Science Foundation of China

Animals1

Outcomes

3

Cellular senescence

downin cells1

1 study

Nicotinamide mononucleotide + huc-mscs decrease cellular senescence in cells.
“combined treatment with hUC-MSCs and NMN alleviated cellular senescence in lymphocytes”
Cellslymphocytes
Enhancing the anti-ageing capacity of hUC-MSCs via NMN co-treatment in D-galactose-induced ageing mice and cellular senescence models
Mechanisms of ageing and development28 Jul 2026

More on Cellular senescence

Motor and cognitive functions

upin mice1

1 study

Nicotinamide mononucleotide + huc-mscs improve motor and cognitive functions in mice.
“significant improvement in motor and cognitive functions in D-galactose-induced ageing mice”
Animalsin D-galactose-induced ageing mice
Enhancing the anti-ageing capacity of hUC-MSCs via NMN co-treatment in D-galactose-induced ageing mice and cellular senescence models
Mechanisms of ageing and development28 Jul 2026

Thymic and splenic atrophy

downin mice1

1 study

Nicotinamide mononucleotide + huc-mscs decrease thymic and splenic atrophy in mice.
“marked alleviation of thymic and splenic atrophy, attenuation of body weight loss, and significant improvement in motor and cognitive functions in D-galactose-induced ageing mice”
Animalsin D-galactose-induced ageing mice
Enhancing the anti-ageing capacity of hUC-MSCs via NMN co-treatment in D-galactose-induced ageing mice and cellular senescence models
Mechanisms of ageing and development28 Jul 2026

Latest

1 in 12 months

Mechanisms of Ageing and Development29 Jul

Enhancing the anti-ageing capacity of hUC-MSCs via NMN co-treatment in D-galactose-induced ageing mice and cellular senescence models

Experiments in miceNicotinamide mononucleotide